Trillium Therapeutics Inc. Debt to Equity Ratio 2014-2021 | TRIL
Current and historical debt to equity ratio values for Trillium Therapeutics Inc. (TRIL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Trillium Therapeutics Inc. debt/equity for the three months ending September 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-09-30 | $0.02B | $0.24B | 0.09 |
| 2021-06-30 | $0.01B | $0.26B | 0.05 |
| 2021-03-31 | $0.02B | $0.27B | 0.06 |
| 2020-12-31 | $0.02B | $0.28B | 0.08 |
| 2020-09-30 | $0.11B | $0.18B | 0.62 |
| 2020-06-30 | $0.07B | $0.07B | 0.97 |
| 2020-03-31 | $0.06B | $0.08B | 0.66 |
| 2019-12-31 | $0.03B | $-0.00B | -20.80 |
| 2019-09-30 | $0.01B | $0.02B | 0.64 |
| 2019-06-30 | $0.01B | $0.03B | 0.42 |
| 2019-03-31 | $0.02B | $0.03B | 0.46 |
| 2018-12-31 | $0.01B | $0.03B | 0.33 |
| 2018-09-30 | $0.01B | $0.04B | 0.28 |
| 2018-06-30 | $0.01B | $0.05B | 0.25 |
| 2018-03-31 | $0.01B | $0.06B | 0.22 |
| 2017-12-31 | $0.01B | $0.06B | 0.20 |
| 2017-09-30 | $0.01B | $0.05B | 0.20 |
| 2017-06-30 | $0.01B | $0.06B | 0.16 |
| 2017-03-31 | $0.01B | $0.04B | 0.21 |
| 2016-12-31 | $0.01B | $0.04B | 0.15 |
| 2016-09-30 | $0.01B | $0.05B | 0.11 |
| 2016-06-30 | $0.01B | $0.06B | 0.10 |
| 2016-03-31 | $0.01B | $0.06B | 0.08 |
| 2015-12-31 | $0.00B | $0.07B | 0.05 |
| 2015-09-30 | $0.00B | $0.07B | 0.05 |
| 2015-06-30 | $0.00B | $0.07B | 0.04 |
| 2015-03-31 | $0.00B | $0.02B | 0.16 |
| 2014-12-31 | $0.00B | $0.02B | 0.16 |
| 2014-09-30 | $0.00B | $0.03B | 0.07 |
| 2014-06-30 | $0.00B | $0.03B | 0.05 |
| 2014-03-31 | $0.00B | $0.03B | 0.04 |
| 2013-12-31 | $0.00B | $0.03B | 0.04 |
| 2013-09-30 | $0.00B | $0.00B | 0.28 |
| 2013-06-30 | $0.00B | $0.01B | 0.20 |
| 2013-03-31 | $0.00B | $0.00B | 0.13 |
